Implementation of an Oral Chemotherapy Adherence Intervention

Recruiting now · Not applicable

Conditions studied: Solid Tumor, Hematologic Malignancy

In brief

The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer clinics (two academic, two urban, and two rural). The study will include 160 adult participants with either solid tumors or hematologic malignancies who have been taking oral anticancer agents for at least six months. This study will have two groups of participants, a pre- and post-implementation group. In the pre-implementation of the program group, investigators will administer a survey to the 80 participants and gather information about their medication prior to their enrollment of the program. Similarly, 80 participants who have been enrolled into this program for at least 6 months will serve as the post-implementation group. These patients will be administered the same survey. The results from both groups will be analyzed to see how effective the medication adherence program is.

Key facts

Study ID

NCT06989489

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

160

Starts

2025-05-28

Expected to finish

2028-08-30

Last updated by the study team

2026-07-08

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age ≥21 years-old) patients
• Diagnosed with a solid or hematologic malignancy
• Monotherapy on oral anticancer agent on treatment for at least 6 months

You may not qualify if…

• Patients on time-limited or intermittent therapy (non-continuous)
• Patients on comfort (end-of-life) care
• Patients enrolled on hospice

Where it is running

• UNC Chapel Hill — Chapel Hill, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.